Ards

(redirected from adult respiratory distress syndrome)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.
Related to adult respiratory distress syndrome: acute renal failure, bronchiectasis, emphysema, pneumothorax, sepsis, pulmonary edema, Acute Respiratory Failure, disseminated intravascular coagulation

Ards

a district of Northern Ireland, in Co. Down. Pop.: 74 369 (2003 est.). Area: 368 sq. km (142 sq. miles)
References in periodicals archive ?
Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome.
ECMO, as rescue therapy for adult respiratory distress syndrome, appears to be an unvalidated rescue treatment option.
The patient died from severe adult respiratory distress syndrome (Figure 1B) with multiorgan failure the next day.
Previously, Cannabis Science has emphasized the importance of addressing the threat presented by Adult Respiratory Distress Syndrome (ARDS).
BL-3030 is aimed at inhibiting the formation of cPLA2 - an enzyme that plays a major role in a number of inflammatory diseases including rheumatoid arthritis (RA), asthma, and adult respiratory distress syndrome (ARDS).
The hantavirus epidemic in the Southwest: rodent population dynamics and the implications for transmission of hantavirus-associated adult respiratory distress syndrome (HARDS) in the Four Comers region.
If funding is obtained, the Company plans to direct its efforts to the development of Thymosin B4, which could have applications in the treatment of sepsis, adult respiratory distress syndrome, chronic bronchitis, asthma, and cystic fibrosis.
While not reported in patients receiving Neulasta, rare events of adult respiratory distress syndrome have been reported in patients receiving the parent compound, Filgrastim.
T Cell completed its first Phase I clinical trial of TP10 last July, for patients with Adult Respiratory Distress Syndrome (ARDS).
Nasdaq: TCEL) today announced the start of a Phase IIa trial evaluating the use of the Company's lead complement inhibitor, TP10, in patients with Adult Respiratory Distress Syndrome (ARDS).
In October of this year, T Cell completed its first Phase I clinical trial of TP10 for patients with Adult Respiratory Distress Syndrome (ARDS).
In July of this year, T Cell completed Phase I clinical trials which indicate soluble complement receptor 1, (product name TP10), is safe, and can inhibit complement activation in adult patients at risk for Adult Respiratory Distress Syndrome (ARDS).

Full browser ?